269 related articles for article (PubMed ID: 38503745)
1. The role of RNA-modifying proteins in renal cell carcinoma.
Alhammadi MA; Bajbouj K; Talaat IM; Hamoudi R
Cell Death Dis; 2024 Mar; 15(3):227. PubMed ID: 38503745
[TBL] [Abstract][Full Text] [Related]
2. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
3. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
4. N
von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J
Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994
[TBL] [Abstract][Full Text] [Related]
5. Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.
Li L; Miao W; Huang M; Williams P; Wang Y
Mol Cell Proteomics; 2019 Mar; 18(3):437-447. PubMed ID: 30487242
[TBL] [Abstract][Full Text] [Related]
6. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
Chow TF; Mankaruos M; Scorilas A; Youssef Y; Girgis A; Mossad S; Metias S; Rofael Y; Honey RJ; Stewart R; Pace KT; Yousef GM
J Urol; 2010 Feb; 183(2):743-51. PubMed ID: 20022054
[TBL] [Abstract][Full Text] [Related]
7. Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.
Siebenthall KT; Miller CP; Vierstra JD; Mathieu J; Tretiakova M; Reynolds A; Sandstrom R; Rynes E; Haugen E; Johnson A; Nelson J; Bates D; Diegel M; Dunn D; Frerker M; Buckley M; Kaul R; Zheng Y; Himmelfarb J; Ruohola-Baker H; Akilesh S
EBioMedicine; 2019 Mar; 41():427-442. PubMed ID: 30827930
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Zaman S; Hajiran A; Coba GA; Robinson T; Madanayake TW; Segarra DT; Chobrutskiy BI; Boyle TA; Zhou JM; Kim Y; Mulé JJ; Teer JK; Manley BJ
Eur Urol Focus; 2021 Mar; 7(2):373-380. PubMed ID: 31901438
[TBL] [Abstract][Full Text] [Related]
10. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.
Zheng Z; Zeng X; Zhu Y; Leng M; Zhang Z; Wang Q; Liu X; Zeng S; Xiao Y; Hu C; Pang S; Wang T; Xu B; Peng P; Li F; Tan W
Mol Cancer; 2024 Jan; 23(1):4. PubMed ID: 38184608
[TBL] [Abstract][Full Text] [Related]
11. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
Deville JL; Bartoli C; Berenguer C; Fernandez-Sauze S; Kaafarani I; Delfino C; Fina F; Salas S; Muracciole X; Mancini J; Lechevallier E; Martin PM; Figarella-Branger D; Ouafik L; Daniel L
Int J Cancer; 2009 Nov; 125(10):2307-15. PubMed ID: 19610056
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
17. Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells.
Wu Y; Liu J; Zheng Y; You L; Kuang D; Liu T
Tumour Biol; 2014 Dec; 35(12):11887-94. PubMed ID: 25149152
[TBL] [Abstract][Full Text] [Related]
18. RNA N
Ni WJ; Lu H; Ma NN; Hou BB; Zeng J; Zhou H; Shao W; Meng XM
Br J Pharmacol; 2023 Jan; 180(1):5-24. PubMed ID: 36196023
[TBL] [Abstract][Full Text] [Related]
19. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
[TBL] [Abstract][Full Text] [Related]
20. Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
Yuan H; Qin X; Yang Q; Liu L; Fang Z; Fan Y; Xu D
Biol Sex Differ; 2023 Jul; 14(1):46. PubMed ID: 37434223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
